Cimetidine: An inhibitor and an inducer of rat liver microsomal cytochrome P-450

References

• Adedoyin A., Aarons L., Houston J. B. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat. Drug Metabolism and Disposition 1987; 15: 127–132
   PubMed Web of Science ®Google Scholar
• Bartle W. R., Walker S. E., Shapero T. Dose-dependent effect of cimetidine on phenytoin kinetics. Clinical Pharmacology and Therapeutics 1983; 33: 649–655
   PubMed Web of Science ®Google Scholar
• Burnet F., Darby N., Lodola A. On the inducibility of cytochrome P-450. Bioessays 1986; 4: 231–232
   PubMed Web of Science ®Google Scholar
• Carr K. E., Toner P. G. Cell Structure: An Introduction to Biomedical Electron Microscopy3rd edn. Churchill Livingstone, Edinburgh 1982
   Google Scholar
• Cochran W. G., Cox G. M. chapter 7. Experimental Designs. Wiley, New York 1957
   Google Scholar
• Donn K. II., Powell J. R., Rogers J. F., Eshelman F. N. The influence of H2-receptor antagonists on the steady state concentrations of propranolol and 4-hydroxypropranolol. Journal of Clinical Pharmacology 1984; 24: 500–508
   PubMed Web of Science ®Google Scholar
• Drew R. J., Powell J., Grygiel J. J. Cimetidine: a specific inhibitor of hepatic aryl hydrocarbon hydroxylase in the rat. Research Communications in Chemical and Pathological Physiology 1981; 33: 81–93
   PubMedGoogle Scholar
• Duggleby R. G. Regression analysis of nonlinear Arrhenius plots: an empirical model and a computer program. Computers in Biology and Medicine 1984; 14: 447–455
   PubMed Web of Science ®Google Scholar
• Estabrook R. W., Peterson J., Baron J., Hildebrant A. The spectrophotometric measurement of turbid suspensions of cytochromes associated with drug metabolism. Methods in Pharmacology, C. F. Chignell. Appleton-Century-Crofts, New York 1972; vol. 2: 303–350
   Google Scholar
• Fouts J. R., Rogers L. A. Morphological changes in the liver accompanying stimulation of microsomal drug metabolizing enzyme activity by phenobarbital, chlordane, benzpyrene or methylcholanthrene in rats. Journal of Pharmacology and Experimental Therapeutics 1965; 147: 112–119
   PubMed Web of Science ®Google Scholar
• Galbraith R. A., Jellinck P. H. Decreased estrogen hydroxylation in male rat liver following cimetidine treatment. Biochemical Pharmacology 1989; 38: 315–319
   Web of Science ®Google Scholar
• Gerber M. C., Tejwani G. A., Gerber N., Bianchine J. R. Drug interactions with cimetidine: an update. Pharmacology and Therapeutics in Dentistry 1985; 27: 353–370
   Google Scholar
• Gonzalez F. J., Matsunaga T., Nagata K., Meyer U. A., Nebert D. W., Pastewka J., Kozak C. A., Gillette J., Gelboin H. V., Hardwick J. P. Debrisoquine 4-hydroxylase: characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism. DNA 1987; 6: 149–161
   PubMedGoogle Scholar
• Guengerich F. P. Microsomal enzymes involved in toxicology—analysts and separation. Principles and Methods of Toxicology, A. W. Hayes. Raven Press, New York 1982; 609–634
   Google Scholar
• Guengerich F. P. Enzymology of rat liver cytochromes P-450. Mammalian Cytochromes P-450, F. P. Guengerich. CRC Press, Boca Raton, FL 1987; vol. 1: 1–54
   Google Scholar
• Ioannides C., Rodrigues A. D., Ayrton A. D., Barnett C. R., Chown J., Parke D. V. Induction of the rat hepatic microsomal mixed-function oxidases by cimetidine. Toxicology Letters 1989; 49: 61–68
   PubMed Web of Science ®Google Scholar
• Ioannoni B., Mason S. R., Reilly P. E. B., Winzor D. J. Evidence for induction of hepatic microsomal cytochrome P450 by cimetidine: binding and kinetic studies. Archives of Biochemistry and Biophysics 1986; 247: 372–383
   PubMed Web of Science ®Google Scholar
• Iversen P. L., Hines R. N., Bresnick E. The molecular biology of the polycyclic aromatic hydrocarbon inducible cytochrome P-450; the past is prologue. Bioessays 1986; 4: 15–19
   PubMed Web of Science ®Google Scholar
• Jensen J. C., Gugler R. Cimetidine interaction with liver microsomes in vitro and in vivo. Biomedical Pharmacology 1985; 34: 2141–2146
   Google Scholar
• Kahl R., Friederici D. E., Kahl G. F., Ritter W., Krebs R. Clotrimazole as an inhibitor of benzo‘a’pyrene metabolite-DNA adduct formation in vitro and of microsomal monooxygenase activity. Drug Metabolism and Disposition 1980; 8: 191–196
   PubMed Web of Science ®Google Scholar
• Kanai K., Kanamura S., Asada-Kubota M., Wantanabe J., Oka M. Quantitative analysis of smooth endoplasmic reticulum proliferation in hepatocytes of early postnatal and adult mice. Gastroenterology 1984; 87: 1131–1137
   PubMed Web of Science ®Google Scholar
• Larrey D., Distlerath L. M., Dannan G. A., Wilkinson G. R., Guengerich F. P. Purification and characterization of the rat liver microsomal cytochrome P450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. Biochemistry 1984; 23: 2787–2795
   PubMed Web of Science ®Google Scholar
• Lennard M. S., Crewe H. K., Tucker G. T., Woods H. F. Metroprolol oxidation by rat liver microsomes: inhibition by debrisoquine and other drugs. Biochemical Pharmacology 1986; 35: 2757–2761
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Milhaley G. W., Smallwood R. A., Anderson J. D., Jones B. D., Webster L. K., Vadja F. J. H2-receptor antagonists and hepatic drug disposition. Hepatology 1983; 2: 828–831
   Web of Science ®Google Scholar
• Nebert D. W., Nelson D. R., Adesnik M., Coon M. J., Estabrook R. W., Gonzalez F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Kemper B., Levin W., Phillips I. R., Sato R., Waterman M. R. The P450 superfamily: Updated listing of all genes and recommended nomenclature for the chromosomal loci. DNA 1989; 8: 1–13
   PubMedGoogle Scholar
• Orrenius S., Ericsson J. I. E., Ernster L. Phenobarbital-induced synthesis of the microsomal drug metabolizing enzyme system and its relationship to the proliferation of endoplasmic membranes. Journal of Cell Biology 1965; 25: 627–639
   PubMed Web of Science ®Google Scholar
• Reichen J., Hoilien C., Kirshenbaum G. R. Cimetidine induces hepatic heme oxygenase activity without altering hepatic heme catabolism. Experientia 1986; 42: 942–945
   PubMedGoogle Scholar
• Reilly P. E. B., Carrington L. E., Winzor D. J. The interaction of cimetidine with rat liver microsomes. Biochemical Pharmacology 1983; 32: 831–835
   PubMed Web of Science ®Google Scholar
• Reynolds E. S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. Journal of Cell Biology 1963; 17: 208–212
   PubMed Web of Science ®Google Scholar
• Ritter J. K., Franklin M. R. Induction of rat hepatic drug metabolism by N-substituted imidizole drugs. Drug Metabolism and Disposition 1987; 15: 335–343
   PubMed Web of Science ®Google Scholar
• Roberts R. K., Heath C. A., Johnson R. F., Speeg K. V., Jr, Schenker S. Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver. Journal of Laboratory and Clinical Medicine 1986; 107: 112–117
   PubMed Web of Science ®Google Scholar
• Salem R. B., Breland B. D., Mishra S. K., Jordan J. E. Effect of cimetidine on phenytoin serum levels. Epilepsia 1983; 24: 284–288
   PubMed Web of Science ®Google Scholar
• Sedman A. J. Cimetidine-drug interactions. American Journal of Medicine 1984; 76: 109–114
   PubMed Web of Science ®Google Scholar
• Serlin M. J., Challiner M., Park B. M., Turcan P. A., Breckenridge A. M. Cimetidine potentiates the anticoagulant effect of warfarin by inhibition of drug metabolism. Biochemical Pharmacology 1980; 29: 1971–1972
   PubMed Web of Science ®Google Scholar
• Somogyi A., Gugler R. Drug interactions with cimetidine. Clinical Pharmacokinetics 1982; 7: 23–41
   PubMed Web of Science ®Google Scholar
• Tucker G. T., Lennard M. S., Otton V. S., Jackson P. R., Ramsay L. E., Woods H. F. Pharmokinetic and pharmacodynamic consequences of Beta-adrenoreceptor blocker oxidation polymorphism in man. Microsomes and Drug Oxidations, Proceedings of the VII international symposium, J. Miners, D. J. Birkett, R. Drew, M. McManus. Taylor & Francis, London 1987; 224–231
   Google Scholar
• Vestal R. E., Thummel K. E., Musser B., Mercer G. D. Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration. British Journal of Clinical Pharmacology 1983; 15: 411–418
   PubMed Web of Science ®Google Scholar